Blockchain is not only the preserve of the fintech industry, but may have multiple uses for life sciences companies, including providing a consent structure for clinical trials to give enhanced patients more control over their own data. Sidley’s Eva von Mühlenen and Daniel Fritz, executive director of the PharmaLedger Association, explain.

The post Beyond Technology: Embracing Blockchain for a Paradigm Shift in Life Sciences appeared first on GoodLifeSci.